Premature coronary artery disease and early stage chronic kidney disease

A M Price, C J Ferro, M K Hayer, R P Steeds, N C Edwards, J N Townend

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)
74 Downloads (Pure)

Abstract

A 30 year old asymptomatic male with stage 3 chronic kidney disease (CKD) secondary to Focal Segmental Glomerulosclerosis was found to have features of CKD associated cardiomyopathy including left ventricular hypertrophy (LVH) and focal subendocardial scarring on cardiac magnetic resonance imaging. There was also a significantly raised CT coronary calcium score and evidence of non-flow limiting coronary artery disease (CAD) on a CT coronary angiogram. Early stage CKD is a major risk factor for cardiovascular risk causing myocardial hypertrophy and fibrosis and coronary artery atheroma. Cardiovascular risk begins to
increase from an eGFR of around 75ml/min/1.73m2. The pathophysiology of cardiovascular disease in CKD is under investigation but to date, treatment options are limited. Blood pressure control and statins have the strongest supportive evidence.
Original languageEnglish
Pages (from-to)683–686
JournalQJM: An International Journal of Medicine
Volume111
Issue number10
DOIs
Publication statusPublished - 18 Sep 2017

Fingerprint

Dive into the research topics of 'Premature coronary artery disease and early stage chronic kidney disease'. Together they form a unique fingerprint.

Cite this